Please sign in to follow a disease.
Prostate cancer frailty study aims to improve care for older men
NCT ID NCT07605936
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 80 men aged 65 and older with prostate cancer in Ireland. Researchers will measure frailty, daily functioning, and quality of life over 12 months. The goal is to see how well current frailty screening tools predict health outcomes, helping doctors tailor care for older patients.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors better identify frail prostate cancer patients who need extra support.
- What could go wrong
- This is an observational study, not a treatment trial. It will not directly improve health, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 80 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Apr 2026
- Expected to finish
-
Nov 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
All adults ≥ 65 years old with prostate attending outpatient clinics at the Mid-Western Cancer Centre between April 2026 and April 2027 (inclusive) will be considered eligible for participation in the study.
- Ages
-
65 years and older
- Sex
-
Male participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * adults aged ≥65 years with a diagnosis of prostate cancer Exclusion Criteria: * Neither the patient nor the carer has sufficient proficiency in English sufficiently to complete consent or baseline assessment * Patients will be excluded if they present outside of research nurse (RN) operational hours( 8am and 5pm Monday - Friday). * Patients who are acutely unwell and unable to answer the questionnaire will also be excluded.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Frailty at older adults are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
University Hospital Limerick
RECRUITINGLimerick, Munster, V94 F858, Ireland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A scanner in the operating room could show surgeons exactly where prostate cancer remains
- New PET tracer aims to light up hidden cancer targets
- Can daily adaptive radiotherapy spare healthy tissue in prostate cancer?
- Can a radioactive tracer and MRI reveal prostate Cancer's true extent?
- Five-Fraction radiation plus hormone therapy tested against High-Risk prostate cancer
- Can a 10-Hour eating window fight cancer fatigue?